Business managers in all areas face cost pressures that keep them up at night. Such is the nature of the business beast. But, those same pressures take on an entirely new dimension within the pharmaceutical sphere. Here, pressure to keep costs low is a matter of life and death, rather than just a demand for convenience.
That’s a whole lot to hold on your shoulders, and the majority of pharmacy execs expect cost pressures to get worse before they get better. That’s a bleak prospect, but it’s also something pharma brands have been coping with since their conception. As such, there are plenty of tried and tested routes for minimising the overall impact of cost pressures without compromising care. Let’s get into them!
# 1 – Outsourcing Services
Developing pharmaceuticals is far from cheap, especially when you consider the need for extensive research teams, numerous manufacturing machines, and rigorous testing processes. If prices were truly accurate for these outlays, medication would be far out of everyone’s reach.
That’s obviously not viable, and it’s something that pharma brands largely offset by outsourcing certain parts of their processes. Outsourcing services like production, packaging and delivery to a CDMO (contract development and manufacturing organisation) is a particularly wise cost-saving option, as it ensures fast, affordable expert drug development for a fraction of the costs that would come from keeping similar processes in-house.
CROs (clinical research organisations) are another fantastic outsourcing option, as they can handle expensive parts of the research process, including the clinical trials and data analysis that would otherwise cost pharma companies months, or even years, of time and budget.
# 2 – Integrating Advanced Technologies
According to McKinsey, digital transformation initiatives stand to reduce the cost of pharmaceutical operations by 15-30%, which highlights the importance of integrating advanced technologies across the pharma food chain.
Automotive technologies like robotic process automation (RPA) are particularly valuable for their ability to automate routine administrative tasks, while artificial intelligence (AI) sits at the forefront of both drug discovery, and the speed with which development is possible. The use of generative AI in pharma is particularly notable for its cost-saving potential right now as it stands to streamline everything from drug discovery to clinical trials, and even previously drawn-out regulatory approvals.
# 3 – Utilising Predictive Analytics
Much of what pharmaceutical companies do feels like a financial shot in the dark, resulting in losses due to everything from overproduction to poorly designed clinical trials. These losses are behind some of the worst financial setbacks in the industry, but improvements could be possible if companies put predictive analytics to full use.
From foreseeing equipment failure to more accurately predicting drug demand, advanced analytics could lead to significant savings at every stage of pharmaceutical research and production. The ability to make evidence-based decisions at all times could prove particularly transformative from a spending standpoint, ensuring that decisions are always as financially sensible as possible.
There’s no getting around the cost pressures faced by pharmaceutical companies, but these tips could well see you coping a little better with this constant problem.